메뉴 건너뛰기




Volumn 19, Issue 21, 2013, Pages 3766-3772

Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension

Author keywords

Cardiovascular disease; Chlorthalidone; Hydrochlorothiazide; Hypertension; Thiazide diuretics

Indexed keywords

AMILORIDE; AMLODIPINE; BENAZEPRIL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; GLUCOSE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METOPROLOL; PLACEBO; POTASSIUM; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; TRIAMTERENE; TRICHLORMETHIAZIDE; URIC ACID;

EID: 84878647332     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990315     Document Type: Article
Times cited : (9)

References (98)
  • 1
    • 70449851433 scopus 로고    scopus 로고
    • Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
    • European Society of Hypertension
    • Mancia G, Laurent S, Agabiti-Rosei E, et al; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-58.
    • (2009) J Hypertens , vol.27 , pp. 2121-2158
    • Mancia, G.1    Laurent, S.2    Agabiti-Rosei, E.3
  • 2
    • 0038460302 scopus 로고    scopus 로고
    • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
    • National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee
    • Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
    • (2003) JAMA , vol.289 , pp. 2560-2572
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 3
    • 72049116836 scopus 로고    scopus 로고
    • Use of diuretics in patients with hypertension
    • Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009; 361: 2153-64.
    • (2009) N Engl J Med , vol.361 , pp. 2153-2164
    • Ernst, M.E.1    Moser, M.2
  • 4
    • 58149457772 scopus 로고    scopus 로고
    • All thiazide-like diuretics are not chlorthalidone: Putting the ACCOMPLISH study into perspective
    • Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich) 2009; 11: 5-10.
    • (2009) J Clin Hypertens (Greenwich) , vol.11 , pp. 5-10
    • Ernst, M.E.1    Carter, B.L.2    Basile, J.N.3
  • 5
    • 79953243999 scopus 로고    scopus 로고
    • Evidencebased diuretic therapy for improving cardiovascular prognosis in systemic hypertension
    • Al Badarin FJ, Abuannadi MA, Lavie CJ, O'Keefe JH. Evidencebased diuretic therapy for improving cardiovascular prognosis in systemic hypertension. Am J Cardiol 2011; 107: 1178-84.
    • (2011) Am J Cardiol , vol.107 , pp. 1178-1184
    • Al Badarin, F.J.1    Abuannadi, M.A.2    Lavie, C.J.3    O'Keefe, J.H.4
  • 6
    • 77949653924 scopus 로고    scopus 로고
    • Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium
    • Ernst ME, Carter BL, Zheng S, Grimm RH Jr. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens 2010; 23: 440-6.
    • (2010) Am J Hypertens , vol.23 , pp. 440-446
    • Ernst, M.E.1    Carter, B.L.2    Zheng, S.3    Grimm Jr., R.H.4
  • 7
    • 79953219740 scopus 로고    scopus 로고
    • Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: A retrospective cohort analysis
    • Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011; 57: 689-94.
    • (2011) Hypertension , vol.57 , pp. 689-694
    • Dorsch, M.P.1    Gillespie, B.W.2    Erickson, S.R.3    Bleske, B.E.4    Weder, A.B.5
  • 8
    • 0346102472 scopus 로고    scopus 로고
    • Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability
    • Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004; 43: 4-9.
    • (2004) Hypertension , vol.43 , pp. 4-9
    • Carter, B.L.1    Ernst, M.E.2    Cohen, J.D.3
  • 9
    • 27744579877 scopus 로고    scopus 로고
    • Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
    • Khosla N, Chua DY, Elliott WJ, Bakris GL. Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications? J Clin Hypertens (Greenwich) 2005; 7: 354-6.
    • (2005) J Clin Hypertens (Greenwich) , vol.7 , pp. 354-356
    • Khosla, N.1    Chua, D.Y.2    Elliott, W.J.3    Bakris, G.L.4
  • 10
    • 84861532412 scopus 로고    scopus 로고
    • Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate
    • Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension 2012; 59: 1104-9.
    • (2012) Hypertension , vol.59 , pp. 1104-1109
    • Peterzan, M.A.1    Hardy, R.2    Chaturvedi, N.3    Hughes, A.D.4
  • 11
    • 33644981542 scopus 로고    scopus 로고
    • Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
    • Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006; 47: 352-8.
    • (2006) Hypertension , vol.47 , pp. 352-358
    • Ernst, M.E.1    Carter, B.L.2    Goerdt, C.J.3
  • 12
    • 21744446081 scopus 로고    scopus 로고
    • Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study
    • Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46: 156-61.
    • (2005) Hypertension , vol.46 , pp. 156-161
    • Dolan, E.1    Stanton, A.2    Thijs, L.3
  • 13
    • 15744389626 scopus 로고    scopus 로고
    • Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide
    • Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide. Am J Hypertens 2005; 18: 398-402.
    • (2005) Am J Hypertens , vol.18 , pp. 398-402
    • Finkielman, J.D.1    Schwartz, G.L.2    Chapman, A.B.3    Boerwinkle, E.4    Turner, S.T.5
  • 14
    • 79251482197 scopus 로고    scopus 로고
    • Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: A meta-analysis of randomized trials
    • Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol 2011; 57: 590-600.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 590-600
    • Messerli, F.H.1    Makani, H.2    Benjo, A.3    Romero, J.4    Alviar, C.5    Bangalore, S.6
  • 15
    • 78649365900 scopus 로고    scopus 로고
    • The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis
    • Karagiannis A, Tziomalos K, Anagnostis P, et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol 2010; 8: 792-803.
    • (2010) Curr Vasc Pharmacol , vol.8 , pp. 792-803
    • Karagiannis, A.1    Tziomalos, K.2    Anagnostis, P.3
  • 17
    • 0019364057 scopus 로고
    • Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: A double-blind controlled trial
    • Grimm RH Jr, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med 1981; 94: 7-11.
    • (1981) Ann Intern Med , vol.94 , pp. 7-11
    • Grimm Jr., R.H.1    Leon, A.S.2    Hunninghake, D.B.3    Lenz, K.4    Hannan, P.5    Blackburn, H.6
  • 18
    • 0033594220 scopus 로고    scopus 로고
    • Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
    • Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1999; 159: 551-8.
    • (1999) Arch Intern Med , vol.159 , pp. 551-558
    • Lakshman, M.R.1    Reda, D.J.2    Materson, B.J.3    Cushman, W.C.4    Freis, E.D.5
  • 19
    • 9344253821 scopus 로고    scopus 로고
    • Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group
    • Grimm RH Jr, Flack JM, Grandits GA, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996; 275: 1549-56.
    • (1996) JAMA , vol.275 , pp. 1549-1556
    • Grimm Jr., R.H.1    Flack, J.M.2    Grandits, G.A.3
  • 20
    • 0027182440 scopus 로고
    • Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss
    • Bradley K, Flack JM, Belcher J, Elmer P, Miller P, Grimm R Jr. Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss. Am J Hypertens 1993; 6: 636-9.
    • (1993) Am J Hypertens , vol.6 , pp. 636-639
    • Bradley, K.1    Flack, J.M.2    Belcher, J.3    Elmer, P.4    Miller, P.5    Grimm Jr., R.6
  • 21
    • 84870826740 scopus 로고    scopus 로고
    • Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
    • Christogiannis LG, Kostapanos MS, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension. J Hum Hypertens 2013; 27: 44-50.
    • (2013) J Hum Hypertens , vol.27 , pp. 44-50
    • Christogiannis, L.G.1    Kostapanos, M.S.2    Tellis, C.C.3    Milionis, H.J.4    Tselepis, A.D.5    Elisaf, M.S.6
  • 22
    • 0032513534 scopus 로고    scopus 로고
    • Influence of long-term, lowdose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group
    • Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, lowdose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998; 158: 741-51.
    • (1998) Arch Intern Med , vol.158 , pp. 741-751
    • Savage, P.J.1    Pressel, S.L.2    Curb, J.D.3
  • 23
    • 0030730635 scopus 로고    scopus 로고
    • An effective approach for treating elderly patients with isolated systolic hypertension: Results of an Italian multicenter study with fosinopril
    • Leonetti G, Trimarco B, Collatina S, Tosetti A. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. Am J Hypertens 1997; 10: 230S-235S.
    • (1997) Am J Hypertens , vol.10
    • Leonetti, G.1    Trimarco, B.2    Collatina, S.3    Tosetti, A.4
  • 24
    • 84857039982 scopus 로고    scopus 로고
    • Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol
    • Smith SM, Gong Y, Turner ST, et al. Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol. Am J Hypertens 2012; 25: 359-65.
    • (2012) Am J Hypertens , vol.25 , pp. 359-365
    • Smith, S.M.1    Gong, Y.2    Turner, S.T.3
  • 25
    • 84942005552 scopus 로고
    • Is thiazideproduced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program
    • Langford HG, Blaufox MD, Borhani NO, et al. Is thiazideproduced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987; 147: 645-9.
    • (1987) Arch Intern Med , vol.147 , pp. 645-649
    • Langford, H.G.1    Blaufox, M.D.2    Borhani, N.O.3
  • 26
    • 13644253783 scopus 로고
    • The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial
    • Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991; 90: 50S-54S.
    • (1991) Am J Med , vol.90
    • Staessen, J.1
  • 28
    • 33846023704 scopus 로고    scopus 로고
    • Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
    • Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant 2007; 22: 118-27.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 118-127
    • Athyros, V.G.1    Mikhailidis, D.P.2    Liberopoulos, E.N.3
  • 29
    • 34347230840 scopus 로고    scopus 로고
    • Serum uric acid as an independent predictor of early death after acute stroke
    • Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007; 71: 1120-7.
    • (2007) Circ J , vol.71 , pp. 1120-1127
    • Karagiannis, A.1    Mikhailidis, D.P.2    Tziomalos, K.3
  • 31
    • 0033851739 scopus 로고    scopus 로고
    • Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)
    • Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18: 1149-54.
    • (2000) J Hypertens , vol.18 , pp. 1149-1154
    • Franse, L.V.1    Pahor, M.2    Di Bari, M.3
  • 32
    • 0028321729 scopus 로고
    • Diuretic therapy for hypertension and the risk of primary cardiac arrest
    • Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-7.
    • (1994) N Engl J Med , vol.330 , pp. 1852-1857
    • Siscovick, D.S.1    Raghunathan, T.E.2    Psaty, B.M.3
  • 34
    • 0034034398 scopus 로고    scopus 로고
    • Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program
    • Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025-30.
    • (2000) Hypertension , vol.35 , pp. 1025-1030
    • Franse, L.V.1    Pahor, M.2    Di Bari, M.3    Somes, G.W.4    Cushman, W.C.5    Applegate, W.B.6
  • 35
    • 0026531151 scopus 로고
    • Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men
    • Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 1992; 267: 1083-9.
    • (1992) JAMA , vol.267 , pp. 1083-1089
    • Siegel, D.1    Hulley, S.B.2    Black, D.M.3
  • 36
    • 36849022128 scopus 로고    scopus 로고
    • Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
    • Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007; 28: 2937-43.
    • (2007) Eur Heart J , vol.28 , pp. 2937-2943
    • Conen, D.1    Ridker, P.M.2    Mora, S.3    Buring, J.E.4    Glynn, R.J.5
  • 37
    • 0034732256 scopus 로고    scopus 로고
    • Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study
    • Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342: 905-12.
    • (2000) N Engl J Med , vol.342 , pp. 905-912
    • Gress, T.W.1    Nieto, F.J.2    Shahar, E.3    Wofford, M.R.4    Brancati, F.L.5
  • 38
    • 33846294746 scopus 로고    scopus 로고
    • Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis
    • Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369: 201-7.
    • (2007) Lancet , vol.369 , pp. 201-207
    • Elliott, W.J.1    Meyer, P.M.2
  • 39
    • 0020672404 scopus 로고
    • Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium
    • Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983; 32: 106-11.
    • (1983) Diabetes , vol.32 , pp. 106-111
    • Helderman, J.H.1    Elahi, D.2    Andersen, D.K.3
  • 40
    • 33748147006 scopus 로고    scopus 로고
    • Thiazide diuretics, potassium, and the development of diabetes: A quantitative review
    • Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 219-24.
    • (2006) Hypertension , vol.48 , pp. 219-224
    • Zillich, A.J.1    Garg, J.2    Basu, S.3    Bakris, G.L.4    Carter, B.L.5
  • 41
    • 33748139496 scopus 로고    scopus 로고
    • Thiazide-associated glucose abnormalities: Prognosis, etiology, and prevention: Is potassium balance the key?
    • Cutler JA. Thiazide-associated glucose abnormalities: prognosis, etiology, and prevention: is potassium balance the key? Hypertension 2006; 48: 198-200.
    • (2006) Hypertension , vol.48 , pp. 198-200
    • Cutler, J.A.1
  • 43
    • 57449121574 scopus 로고    scopus 로고
    • Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: The mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study
    • Eriksson JW, Jansson PA, Carlberg B, et al. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension 2008; 52: 1030-7.
    • (2008) Hypertension , vol.52 , pp. 1030-1037
    • Eriksson, J.W.1    Jansson, P.A.2    Carlberg, B.3
  • 44
    • 84857132090 scopus 로고    scopus 로고
    • Non-alcoholic Fatty liver disease in type 2 diabetes: Pathogenesis and treatment options
    • Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic Fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol 2012; 10: 162-72.
    • (2012) Curr Vasc Pharmacol , vol.10 , pp. 162-172
    • Tziomalos, K.1    Athyros, V.G.2    Karagiannis, A.3
  • 45
    • 77549087054 scopus 로고    scopus 로고
    • Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
    • Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010; 375: 735-42.
    • (2010) Lancet , vol.375 , pp. 735-742
    • Sattar, N.1    Preiss, D.2    Murray, H.M.3
  • 46
    • 84865147415 scopus 로고    scopus 로고
    • Pharmacotherapy: Statins and newonset diabetes mellitus-a matter for debate
    • Athyros VG, Mikhailidis DP. Pharmacotherapy: Statins and newonset diabetes mellitus-a matter for debate. Nat Rev Endocrinol 2012; 8: 133-4.
    • (2012) Nat Rev Endocrinol , vol.8 , pp. 133-134
    • Athyros, V.G.1    Mikhailidis, D.P.2
  • 48
    • 79551640972 scopus 로고    scopus 로고
    • Preventing type 2 diabetes mellitus: Room for residual risk reduction after lifestyle changes?
    • Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr Pharm Des 2010; 16: 3939-847.
    • (2010) Curr Pharm Des , vol.16 , pp. 3847-3939
    • Athyros, V.G.1    Tziomalos, K.2    Karagiannis, A.3    Mikhailidis, D.P.4
  • 49
    • 2342652390 scopus 로고    scopus 로고
    • Adverse prognostic significance of new diabetes in treated hypertensive subjects
    • Verdecchia P, Reboldi G, Angeli F, et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 2004; 43: 963-9.
    • (2004) Hypertension , vol.43 , pp. 963-969
    • Verdecchia, P.1    Reboldi, G.2    Angeli, F.3
  • 50
    • 0037471841 scopus 로고    scopus 로고
    • Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study
    • Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ 2003; 326: 681.
    • (2003) BMJ , vol.326 , pp. 681
    • Dunder, K.1    Lind, L.2    Zethelius, B.3    Berglund, L.4    Lithell, H.5
  • 51
    • 0032925773 scopus 로고    scopus 로고
    • Diabetes and cardiovascular events in hypertensive patients
    • Alderman MH, Cohen H, Madhavan S. Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130-4.
    • (1999) Hypertension , vol.33 , pp. 1130-1134
    • Alderman, M.H.1    Cohen, H.2    Madhavan, S.3
  • 53
    • 11144228978 scopus 로고    scopus 로고
    • Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
    • SHEP Collaborative Research Group
    • Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR; SHEP Collaborative Research Group. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29-35.
    • (2005) Am J Cardiol , vol.95 , pp. 29-35
    • Kostis, J.B.1    Wilson, A.C.2    Freudenberger, R.S.3    Cosgrove, N.M.4    Pressel, S.L.5    Davis, B.R.6
  • 54
    • 33750999057 scopus 로고    scopus 로고
    • Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Collaborative Research Group
    • Barzilay JI, Davis BR, Cutler JA, et al; ALLHAT Collaborative Research Group. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006; 166: 2191-201.
    • (2006) Arch Intern Med , vol.166 , pp. 2191-2201
    • Barzilay, J.I.1    Davis, B.R.2    Cutler, J.A.3
  • 55
    • 84860859230 scopus 로고    scopus 로고
    • Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study
    • for the ALLHAT Collaborative Research Group
    • Barzilay JI, Davis BR, Pressel SL, et al; for the ALLHAT Collaborative Research Group. Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study. Circ Cardiovasc Qual Outcomes 2012; 5: 153-162.
    • (2012) Circ Cardiovasc Qual Outcomes , vol.5 , pp. 153-162
    • Barzilay, J.I.1    Davis, B.R.2    Pressel, S.L.3
  • 56
    • 10544229794 scopus 로고    scopus 로고
    • Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
    • Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886-92.
    • (1996) JAMA , vol.276 , pp. 1886-1892
    • Curb, J.D.1    Pressel, S.L.2    Cutler, J.A.3
  • 57
    • 22144439426 scopus 로고    scopus 로고
    • Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Collaborative Research Group
    • Whelton PK, Barzilay J, Cushman WC, et al; ALLHAT Collaborative Research Group. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005; 165: 1401-9.
    • (2005) Arch Intern Med , vol.165 , pp. 1401-1409
    • Whelton, P.K.1    Barzilay, J.2    Cushman, W.C.3
  • 58
    • 53049108337 scopus 로고    scopus 로고
    • Metabolic syndrome and incident diabetes: Current state of the evidence
    • Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 2008; 31: 1898-904.
    • (2008) Diabetes Care , vol.31 , pp. 1898-1904
    • Ford, E.S.1    Li, C.2    Sattar, N.3
  • 59
    • 77957198071 scopus 로고    scopus 로고
    • The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis
    • Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-32.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 1113-1132
    • Mottillo, S.1    Filion, K.B.2    Genest, J.3
  • 60
    • 38949084591 scopus 로고    scopus 로고
    • Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    • Black HR, Davis B, Barzilay J, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 2008; 31: 353-60.
    • (2008) Diabetes Care , vol.31 , pp. 353-360
    • Black, H.R.1    Davis, B.2    Barzilay, J.3
  • 61
    • 0018579580 scopus 로고
    • Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group
    • Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242: 2562-71.
    • (1979) JAMA , vol.242 , pp. 2562-2571
  • 62
    • 0020061073 scopus 로고
    • Five-year findings of the hypertension detection and follow-up program III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group
    • Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982; 247: 633-8.
    • (1982) JAMA , vol.247 , pp. 633-638
  • 63
    • 0025831464 scopus 로고
    • Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group
    • Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-64.
    • (1991) JAMA , vol.265 , pp. 3255-3264
  • 64
    • 0030744599 scopus 로고    scopus 로고
    • Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group
    • Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997; 278: 212-6.
    • (1997) JAMA , vol.278 , pp. 212-216
    • Kostis, J.B.1    Davis, B.R.2    Cutler, J.3
  • 65
    • 84255182798 scopus 로고    scopus 로고
    • Association between chlorthalidone treatment of systolic hypertension and long-term survival
    • Kostis JB, Cabrera J, Cheng JQ, et al. Association between chlorthalidone treatment of systolic hypertension and long-term survival. JAMA 2011; 306: 2588-93.
    • (2011) JAMA , vol.306 , pp. 2588-2593
    • Kostis, J.B.1    Cabrera, J.2    Cheng, J.Q.3
  • 66
    • 0344373794 scopus 로고    scopus 로고
    • The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 67
    • 33646766401 scopus 로고    scopus 로고
    • Role of diuretics in the prevention of heart failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    • Davis BR, Piller LB, Cutler JA, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006; 113: 2201-10.
    • (2006) Circulation , vol.113 , pp. 2201-2210
    • Davis, B.R.1    Piller, L.B.2    Cutler, J.A.3
  • 68
    • 0042835370 scopus 로고    scopus 로고
    • Diuretic versus alphablocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alphablocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-46.
    • (2003) Hypertension , vol.42 , pp. 239-246
  • 69
    • 0031861208 scopus 로고    scopus 로고
    • Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program
    • Pahor M, Shorr RI, Somes GW, et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 1998; 158: 1340-5.
    • (1998) Arch Intern Med , vol.158 , pp. 1340-1345
    • Pahor, M.1    Shorr, R.I.2    Somes, G.W.3
  • 70
    • 33644855606 scopus 로고    scopus 로고
    • Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate
    • ALLHAT Collaborative Research Group
    • Rahman M, Pressel S, Davis BR, et al; ALLHAT Collaborative Research Group. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144: 172-80.
    • (2006) Ann Intern Med , vol.144 , pp. 172-180
    • Rahman, M.1    Pressel, S.2    Davis, B.R.3
  • 71
    • 20244371503 scopus 로고    scopus 로고
    • Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • Rahman M, Pressel S, Davis BR, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005; 165: 936-46.
    • (2005) Arch Intern Med , vol.165 , pp. 936-946
    • Rahman, M.1    Pressel, S.2    Davis, B.R.3
  • 72
    • 28844504752 scopus 로고    scopus 로고
    • Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis
    • Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026-33.
    • (2005) Lancet , vol.366 , pp. 2026-2033
    • Casas, J.P.1    Chua, W.2    Loukogeorgakis, S.3
  • 73
    • 43749112197 scopus 로고    scopus 로고
    • Effects of different ACE inhibitor combinations on albuminuria: Results of the GUARD study
    • GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators
    • Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P; GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int 2008; 73: 1303-9.
    • (2008) Kidney Int , vol.73 , pp. 1303-1309
    • Bakris, G.L.1    Toto, R.D.2    McCullough, P.A.3    Rocha, R.4    Purkayastha, D.5    Davis, P.6
  • 74
    • 0021864792 scopus 로고
    • Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
    • Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-54.
    • (1985) Lancet , vol.1 , pp. 1349-1354
    • Amery, A.1    Birkenhäger, W.2    Brixko, P.3
  • 75
    • 0026512315 scopus 로고
    • Medical Research Council trial of treatment of hypertension in older adults: Principal results MRC Working Party
    • Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405-12.
    • (1992) BMJ , vol.304 , pp. 405-412
  • 76
    • 0019197138 scopus 로고
    • Treatment of mild hypertension: A five year controlled drug trial. The Oslo study
    • Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725-32.
    • (1980) Am J Med , vol.69 , pp. 725-732
    • Helgeland, A.1
  • 77
    • 0023433489 scopus 로고
    • Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial
    • Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987; 5: 561-72.
    • (1987) J Hypertens , vol.5 , pp. 561-572
    • Wilhelmsen, L.1    Berglund, G.2    Elmfeldt, D.3
  • 78
    • 0023947123 scopus 로고
    • Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
    • Wikstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA 1988; 259: 1976-82.
    • (1988) JAMA , vol.259 , pp. 1976-1982
    • Wikstrand, J.1    Warnold, I.2    Olsson, G.3    Tuomilehto, J.4    Elmfeldt, D.5    Berglund, G.6
  • 79
    • 0037434556 scopus 로고    scopus 로고
    • A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly
    • Second Australian National Blood Pressure Study Group
    • Wing LM, Reid CM, Ryan P, et al; Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-92.
    • (2003) N Engl J Med , vol.348 , pp. 583-592
    • Wing, L.M.1    Reid, C.M.2    Ryan, P.3
  • 80
    • 0034729993 scopus 로고    scopus 로고
    • Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
    • Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-72.
    • (2000) Lancet , vol.356 , pp. 366-372
    • Brown, M.J.1    Palmer, C.R.2    Castaigne, A.3
  • 81
    • 0037851836 scopus 로고    scopus 로고
    • Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
    • CONVINCE Research Group
    • Black HR, Elliott WJ, Grandits G, et al; CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073-82.
    • (2003) JAMA , vol.289 , pp. 2073-2082
    • Black, H.R.1    Elliott, W.J.2    Grandits, G.3
  • 82
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • ACCOMPLISH Trial Investigators
    • Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-28.
    • (2008) N Engl J Med , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 83
    • 83155180324 scopus 로고    scopus 로고
    • Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial
    • Multiple Risk Factor Intervention Trial Research Group
    • Ernst ME, Neaton JD, Grimm RH Jr, et al; Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 2011; 58: 1001-7.
    • (2011) Hypertension , vol.58 , pp. 1001-1007
    • Ernst, M.E.1    Neaton, J.D.2    Grimm Jr., R.H.3
  • 84
    • 0024520312 scopus 로고
    • Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial
    • MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1989; 63: 202-10.
    • (1989) Am J Cardiol , vol.63 , pp. 202-210
    • McMahon, S.1    Collins, G.2    Rautaharju, P.3
  • 85
    • 23244450974 scopus 로고    scopus 로고
    • Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
    • Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J 2005; 150: 161-7.
    • (2005) Am Heart J , vol.150 , pp. 161-167
    • Hsieh, B.P.1    Pham, M.X.2    Froelicher, V.F.3
  • 86
    • 0025513896 scopus 로고
    • Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial
    • Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990; 82: 1616-28.
    • (1990) Circulation , vol.82 , pp. 1616-1628
  • 87
    • 77955983763 scopus 로고    scopus 로고
    • Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis
    • Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension 2010; 56: 463-70.
    • (2010) Hypertension , vol.56 , pp. 463-470
    • Woodman, R.1    Brown, C.2    Lockette, W.3
  • 88
    • 0034520464 scopus 로고    scopus 로고
    • Effects of antihypertensive treatment on platelet function in essential hypertension
    • Gomi T, Ikeda T, Shibuya Y, Nagao R. Effects of antihypertensive treatment on platelet function in essential hypertension. Hypertens Res 2000; 23: 567-72.
    • (2000) Hypertens Res , vol.23 , pp. 567-572
    • Gomi, T.1    Ikeda, T.2    Shibuya, Y.3    Nagao, R.4
  • 89
    • 3042702505 scopus 로고    scopus 로고
    • Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based lowdose diuretic therapies
    • Psaty BM, Lumley T, Furberg CD. Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based lowdose diuretic therapies. JAMA 2004; 292: 43-4.
    • (2004) JAMA , vol.292 , pp. 43-44
    • Psaty, B.M.1    Lumley, T.2    Furberg, C.D.3
  • 90
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
    • (2009) BMJ , vol.338
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 91
    • 84861531899 scopus 로고    scopus 로고
    • Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: Systematic review and network meta-analyses
    • Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 2012; 59: 1110-7.
    • (2012) Hypertension , vol.59 , pp. 1110-1117
    • Roush, G.C.1    Holford, T.R.2    Guddati, A.K.3
  • 92
    • 0347423198 scopus 로고    scopus 로고
    • National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 93
    • 70449851433 scopus 로고    scopus 로고
    • Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document
    • European Society of Hypertension
    • Mancia G, Laurent S, Agabiti-Rosei E, et al; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-58.
    • (2009) J Hypertens , vol.27 , pp. 2121-2158
    • Mancia, G.1    Laurent, S.2    Agabiti-Rosei, E.3
  • 94
    • 84878655494 scopus 로고    scopus 로고
    • Hypertension
    • National Institute for Health and Clinical Excellence (NICE), [accessed 18/6/2012]
    • National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/ guidance/ CG127 [accessed 18/6/2012].
    • (2011) The clinical management of primary hypertension in adults. Clinical Guideline , vol.127
  • 95
    • 79958101343 scopus 로고    scopus 로고
    • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
    • ACCF Task Force
    • Aronow WS, Fleg JL, Pepine CJ, et al; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123: 2434-506.
    • (2011) Circulation , vol.123 , pp. 2434-2506
    • Aronow, W.S.1    Fleg, J.L.2    Pepine, C.J.3
  • 96
    • 80052379818 scopus 로고    scopus 로고
    • Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly
    • Banach M, Aronow WS. Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn 2011; 121: 253-8.
    • (2011) Pol Arch Med Wewn , vol.121 , pp. 253-258
    • Banach, M.1    Aronow, W.S.2
  • 97
    • 84867397911 scopus 로고    scopus 로고
    • Hypertension therapy in the older adultsdo we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly
    • Banach M, Aronow WS. Hypertension therapy in the older adultsdo we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens 2012; 26: 641-3.
    • (2012) J Hum Hypertens , vol.26 , pp. 641-643
    • Banach, M.1    Aronow, W.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.